Boston Trust Walden Corp Sells 52,205 Shares of U.S. Physical Therapy, Inc. $USPH

Posted by Francis Steltz on Jul 4th, 2026

Boston Trust Walden Corp trimmed its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 11.5% in the 1st quarter, Holdings Channel reports. The firm owned 400,109 shares of the company’s stock after selling 52,205 shares during the period. Boston Trust Walden Corp’s holdings in U.S. Physical Therapy were worth $29,992,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Hantz Financial Services Inc. lifted its position in U.S. Physical Therapy by 56.4% during the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after purchasing an additional 132 shares during the period. Advisory Services Network LLC bought a new stake in U.S. Physical Therapy in the 3rd quarter worth approximately $39,000. EverSource Wealth Advisors LLC raised its stake in U.S. Physical Therapy by 68.8% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock valued at $40,000 after buying an additional 192 shares during the last quarter. GAMMA Investing LLC raised its stake in U.S. Physical Therapy by 207.1% during the 4th quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock valued at $40,000 after buying an additional 348 shares during the last quarter. Finally, iSAM Funds UK Ltd purchased a new stake in U.S. Physical Therapy during the 3rd quarter valued at $52,000.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on USPH shares. Barrington Research dropped their price target on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th. Jefferies Financial Group raised U.S. Physical Therapy to a “strong-buy” rating in a report on Thursday, March 12th. Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Finally, Zacks Research upgraded U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $97.50.

Check Out Our Latest Stock Analysis on USPH

Insider Activity

In other news, Director Peter Francis Minan bought 492 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The shares were bought at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the completion of the transaction, the director owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. This represents a 20.24% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 2.40% of the company’s stock.

U.S. Physical Therapy Price Performance

USPH stock opened at $72.12 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.19 and a current ratio of 1.19. The company’s fifty day moving average price is $65.44 and its 200-day moving average price is $75.34. U.S. Physical Therapy, Inc. has a one year low of $58.19 and a one year high of $93.50. The company has a market capitalization of $1.10 billion, a PE ratio of 144.25, a price-to-earnings-growth ratio of 2.00 and a beta of 1.15.

U.S. Physical Therapy (NYSE:USPH – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.09). The company had revenue of $198.29 million for the quarter, compared to analysts’ expectations of $200.94 million. U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The business’s revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.48 earnings per share. On average, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.99 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 22nd were issued a $0.46 dividend. This represents a $1.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend was Friday, May 22nd. U.S. Physical Therapy’s payout ratio is 368.00%.

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.